Brian D. Brohman

Brian was the previous founding CFO/CBO of biotech startups Aptamera (sold to Antisoma), Bradmer Pharmaceuticals (IPO’d on TSX), and NX PharmaGen (affiliate of NX Prenatal). Prior to these roles, Mr. Brohman served as a licensing/business development professional at J&J’s Cordis medical devices division and is a graduate of the University of Notre Dame’s Mendoza College of Business.